The Food and Drug Administration (FDA) has allowed the sale of Dexcom's Stelo, a continuous glucose monitor (CGM) that children aged two and older can now use without a doctor's prescription.

美國食品藥品監督管理局 (FDA) 已允許銷售 Dexcom 的 Stelo，這是一款持續血糖監測儀 (CGM)，現在兩歲及以上的兒童無需醫生處方即可使用。

The FDA approved the Stelo device to help children and their parents better understand blood sugar levels. By providing real-time data, the agency believes these devices will help families make healthier lifestyle choices, which could reduce the long-term risks of obesity and type 2 diabetes in American youth. The device costs $99 per month and is designed for people with diabetes who do not use insulin, as well as those who want to see how their diet and exercise affect their glucose levels.

FDA 批准了 Stelo 裝置，以幫助兒童及其父母更好地了解血糖水平。該機構認為，透過提供即時數據，這些裝置將幫助家庭做出更健康的生活方式選擇，從而降低美國青少年長期患有肥胖症和 2 型糖尿病的風險。該裝置每月費用為 99 美元，旨在為不使用胰島素的糖尿病患者，以及希望了解飲食和運動如何影響血糖水平的人群設計。

However, experts have different opinions on this decision. Some pediatric doctors argue that removing the prescription requirement makes these tools more accessible to families whose insurance does not cover them. On the other hand, some medical professionals are concerned because there are no official 'normal' blood sugar ranges for children without diabetes. They worry that parents might focus too much on small changes in glucose levels, which could lead to overly strict diets or eating disorders.

然而，專家對此決定持有不同意見。一些兒科醫生認為，取消處方要求使那些保險不涵蓋此類工具的家庭更容易獲得。另一方面，一些醫療專業人士則表示擔憂，因為目前沒有針對非糖尿病兒童的官方「正常」血糖範圍。他們擔心父母可能會過於關注血糖水平的微小變化，從而導致過於嚴格的飲食限制或飲食失調。

Furthermore, while this move follows a general trend toward health technology, there is a lack of specific guidance for children in the device's software. Although some research is currently studying how glucose changes during puberty, doctors are still debating whether it is a good idea to use CGMs on healthy children.

此外，雖然此舉符合健康科技的整體趨勢，但該裝置的軟體中缺乏針對兒童的具體指引。儘管目前有一些研究正在探討青春期血糖變化的情況，但醫生們仍在爭論在健康兒童身上使用 CGM 是否為明智之舉。

The FDA has made glucose monitors more available to children, but this creates a conflict between having more health data and the risk of causing psychological or dietary problems.

FDA 提高了血糖監測儀對兒童的可及性，但這也造成了獲取更多健康數據與面臨心理或飲食問題風險之間的衝突。